#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bulbospinal muscular atrophy congenital Porphyria non-acute Endometrial adenocarcinoma Retinal artery occlusion Uveitis Brain injury Myelodysplastic syndrome Biliary neoplasm Retinal dystrophy Hyperinsulinaemic hypoglycaemia Acute myeloid leukaemia recurrent Andersen-Tawil syndrome Polycythaemia vera Diabetes insipidus Synovial sarcoma recurrent More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II – Diagnostics Gaucher’s disease type III – Treatment Langerhans’ cell histiocytosis – Trials in Disease Medulloblastoma Lymphangiosarcoma – Treatment Isodicentric chromosome 15 syndrome – Basic Information Waldenstrom’s macroglobulinaemia – Diagnostics X-linked lymphoproliferative syndrome – Life with Disease Crigler-Najjar syndrome – Life with Disease Hypereosinophilic syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    IADADEMSTAT Magnesium Oxide, Light Xenon (129Xe) Natalizumab Ixazomib Citrate Esketamine Concizumab LUNSEKIMIG Avalglucosidase Alfa Sildenafil Citrate Progesterone Voxelotor Metamizole Sodium Monohydrate Zinc Acetate Dihydrate Amoxicillin Sodium R3R01 Mometasone Furoate Monohydrate Sepiapterin Obeticholic Acid AZD0292 More therapies…

    Learn about Your Condition

    Thrombocytosis Cutaneous lupus erythematosus Spondylolisthesis Abdominal pain Pancreatic carcinoma stage IV HER2 positive gastric cancer Ulcerative keratitis Systemic mastocytosis Essential hypertension Uveal melanoma Burkitt's lymphoma Dystonia Breast cancer in situ Diabetic ketoacidosis Petit mal epilepsy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on Daridorexant for Treating Insomnia in Patients with Insomnia and Nocturia

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Nocturia
    • Insomnia
    Investigated Drugs:
    • Daridorexant
    Germany Spain

  • Study on the Effectiveness and Safety of Rozanolixizumab for Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOG-AD)

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Rozanolixizumab
    Belgium Czechia France Germany Greece Italy +4

  • Study on the Safety and Tolerability of Exidavnemab in Patients with Mild to Moderate Parkinson’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Parkinson’s disease
    • Multiple system atrophy
    Investigated Drugs:
    • Exidavnemab
    Poland Spain

  • Study on Bepranemab for Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1 1
    Investigated Drugs:
    • 2-(4-(2-[18F]FLUORO-2,2-DIDEUTERO ETHYL)PIPERIDIN-1-YL)BENZO[4,5]IMIDAZO[1,2-A]PYRIMIDINE
    • Bepranemab
    • Florbetaben (18F)
    Belgium France Germany Italy The Netherlands Poland +1

  • Study on Ganaxolone for Patients with Refractory Status Epilepticus

    Not recruiting

    3 1
    Investigated Diseases:
    • Status epilepticus
    Investigated Drugs:
    • Ganaxolone
    Austria Belgium Croatia Czechia Denmark Finland +8

  • Study on the Effects of Leriglitazone for Adult Men with Cerebral Adrenoleukodystrophy

    Not recruiting

    3 1
    Investigated Diseases:
    • Adrenoleukodystrophy
    Investigated Drugs:
    • Leriglitazone
    France Germany Spain
Previous Page
1 … 144 145 146 147
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!